An2 Therapeutics Inc (ANTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANTX | NGEN | TLSA | ||
| Company | An2 Therapeutics Inc | Nervgen Pharma Corp | Tiziana Life Sciences Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.27 | 1.9300 | 1.1800 | ||
| High | 4.45 | 2.1200 | 1.2700 | ||
| Low | 4.16 | 1.9200 | 1.1700 | ||
| Latest | 4.17 | 2.0100 | 1.2700 | ||
| Change | -0.03 | +0.1000 | +0.0900 | ||
| % Change | -0.71% | +5.24% | +7.63% | ||
| Volume | 169,800 | 1,219,400 | 196,600 | ||
| 20-Day Average Volume | 231,800 | 1,411,330 | 278,855 | ||
| Previous Close | 4.20 | 1.9100 | 1.1800 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 4.50 | 2.9500 | 1.4420 | ||
| 20-Day Raw Stochastic | 17.76% | 6.57% | 24.68% | ||
| 20-Day Relative Strength | 49.28 | 28.57 | 44.81 | ||
| Weighted Alpha | +15.51 | -29.14 | -24.65 | ||
| Today's Opinion | 80% Buy | 88% Sell | 64% Sell | ||
| Previous Opinion | 80% Buy | 88% Sell | 64% Sell | ||
| Last Month's Opinion | 100% Buy | 24% Sell | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.50% since 05/28/26 | -3.37% since 05/28/26 | -13.01% since 05/28/26 | ||
| Low | 4.01 on 06/02/26 | 1.8700 on 06/03/26 | 1.0800 on 06/03/26 | ||
| High | 4.65 on 05/29/26 | 2.1300 on 05/29/26 | 1.4800 on 05/29/26 | ||
| 1-Month | |||||
| %Chg | -14.02% since 05/04/26 | -45.08% since 05/04/26 | -8.63% since 05/04/26 | ||
| Low | 3.94 on 05/13/26 | 1.8700 on 06/03/26 | 1.0800 on 06/03/26 | ||
| High | 5.24 on 05/22/26 | 4.0000 on 05/11/26 | 1.8500 on 05/21/26 | ||
| 3-Month | |||||
| %Chg | +211.19% since 03/04/26 | -52.93% since 03/04/26 | -11.19% since 03/04/26 | ||
| Low | 1.32 on 03/05/26 | 1.8700 on 06/03/26 | 1.0800 on 06/03/26 | ||
| High | 6.91 on 03/09/26 | 4.6700 on 04/07/26 | 1.8500 on 05/21/26 | ||
| 6-Month | |||||
| %Chg | +291.55% since 12/04/25 | -51.57% since 12/04/25 | -28.25% since 12/04/25 | ||
| Low | 1.00 on 02/19/26 | 1.8700 on 06/03/26 | 1.0800 on 06/03/26 | ||
| High | 6.91 on 03/09/26 | 6.3000 on 01/08/26 | 1.8500 on 05/21/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 151,267 | 154,005 | 150,166 | ||
| Shares Outstanding, K | 36,016 | 80,631 | 127,259 | ||
| Annual Sales | 0 | 46,920,000 | 0 | ||
| Annual Net Income | -35,170,000 | -38,100,000 | -18,430,000 | ||
| Last Quarter Sales | 0 | 0 | N/A | ||
| Last Quarter Net Income | -10,030,000 | -1,675,549 | N/A | ||
| 60-Month Beta | -0.98 | N/A | 0.44 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.29 on 05/11/26 | -0.09 on 05/15/26 | N/A | ||
| Earnings Date | 08/11/26 | 08/21/26 | 08/07/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||